{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:16:08Z","timestamp":1773810968831,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,25]]},"DOI":"10.7759\/cureus.65324","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T08:31:25Z","timestamp":1721896285000},"source":"Crossref","is-referenced-by-count":2,"title":["Effects of Valproic Acid Supply Shortage on Pharmacy Operations in a Region of Japan"],"prefix":"10.7759","author":[{"given":"Satoru","family":"Matsunuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Sunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanami","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaku","family":"Samizo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Soeishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Jimbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson AG","year":"2007","unstructured":"Marson AG, Al-Kharusi AM, Alwaidh M, et al.. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet. 2007, 369:1000-15. 10.1016\/S0140-6736(07)60460-7","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011412.pub4","article-title":"Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data","volume":"4","author":"Nevitt SJ","year":"2022","unstructured":"Nevitt SJ, Sudell M, Cividini S, Marson AG, Tudur Smith C. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database Syst Rev. 2022, 4:CD011412. 10.1002\/14651858.CD011412.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref3","unstructured":"[Clinical Practice Guideline for Epilepsy] Tenkan Shinryo Guideline 2018 (in Japanese). (2018). Accessed. July 7, 2024: https:\/\/www.neurology-jp.org\/guidelinem\/tenkan_2018.html."},{"key":"ref4","unstructured":"World Health Organization. Defined Daily Dose (DDD). (2024). Accessed: April 28, 2024: https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/about-ddd."},{"key":"ref5","unstructured":"Ministry of Health, Labour and Welfare. The 7th NDB Open Data Commentary. (2022). Accessed: February 20, 2024: https:\/\/www.mhlw.go.jp\/content\/12400000\/001126104.pdf."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2023.03.006","article-title":"Generic drug shortage in japan: GMP noncompliance and associated quality issues","volume":"112","author":"Izutsu KI","year":"2023","unstructured":"Izutsu KI, Ando D, Morita T, Abe Y, Yoshida H. Generic drug shortage in japan: GMP noncompliance and associated quality issues. J Pharm Sci. 2023, 112:1763-71. 10.1016\/j.xphs.2023.03.006","journal-title":"J Pharm Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2016.12.009","article-title":"Stress as a seizure precipitant: Identification, associated factors, and treatment options","volume":"44","author":"McKee HR","year":"2017","unstructured":"McKee HR, Privitera MD. Stress as a seizure precipitant: Identification, associated factors, and treatment options. Seizure. 2017, 44:21-6. 10.1016\/j.seizure.2016.12.009","journal-title":"Seizure"},{"key":"ref8","unstructured":"[Japan Epilepsy Society. Questionnaire survey on antiepileptic drug supply instability issues: results report] Koutenkanyaku kyoukyuu fuantei mondai ni kansuru ankeeto chousa kekka houkokusho (in Japanese). (2022). Accessed: April 29, 2024: https:\/\/jes-jp.org\/pdf\/AED_report20220411.pdf."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.080372","article-title":"A guide for the design and conduct of self-administered surveys of clinicians","volume":"179","author":"Burns KE","year":"2008","unstructured":"Burns KE, Duffett M, Kho ME, Meade MO, Adhikari NK, Sinuff T, Cook DJ. A guide for the design and conduct of self-administered surveys of clinicians. CMAJ. 2008, 179:245-52. 10.1503\/cmaj.080372","journal-title":"CMAJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb00738.x","article-title":"Classification of childhood epilepsy syndromes in newly diagnosed epilepsy: interrater agreement and reasons for disagreement","volume":"40","author":"Berg AT","year":"1999","unstructured":"Berg AT, Levy SR, Testa FM, Shinnar S. Classification of childhood epilepsy syndromes in newly diagnosed epilepsy: interrater agreement and reasons for disagreement. Epilepsia. 1999, 40:439-44. 10.1111\/j.1528-1157.1999.tb00738.x","journal-title":"Epilepsia"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00477.x","article-title":"Prevalence of childhood epilepsy and distribution of epileptic syndromes: a population-based survey in Okayama, Japan","volume":"47","author":"Oka E","year":"2006","unstructured":"Oka E, Ohtsuka Y, Yoshinaga H, Murakami N, Kobayashi K, Ogino T. Prevalence of childhood epilepsy and distribution of epileptic syndromes: a population-based survey in Okayama, Japan. Epilepsia. 2006, 47:626-30. 10.1111\/j.1528-1167.2006.00477.x","journal-title":"Epilepsia"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5698\/1535-7597.17.6.353","article-title":"Worrying more about anxiety in patients with epilepsy","volume":"17","author":"Dworetzky BA","year":"2017","unstructured":"Dworetzky BA. Worrying more about anxiety in patients with epilepsy. Epilepsy Curr. 2017, 17:353-4. 10.5698\/1535-7597.17.6.353","journal-title":"Epilepsy Curr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2022.108988","article-title":"Supply problems of antiseizure medication are common among epilepsy patients in Germany","volume":"138","author":"Mann C","year":"2023","unstructured":"Mann C, Maltseva M, von Podewils F, Knake S, Kovac S, Rosenow F, Strzelczyk A. Supply problems of antiseizure medication are common among epilepsy patients in Germany. Epilepsy Behav. 2023, 138:108988. 10.1016\/j.yebeh.2022.108988","journal-title":"Epilepsy Behav"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2021.106648","article-title":"Impact of a pharmacist-led education and counseling interventions on quality of life in epilepsy: a randomized controlled trial","volume":"174","author":"Eshiet UI","year":"2021","unstructured":"Eshiet UI, Okonta JM, Ukwe CV. Impact of a pharmacist-led education and counseling interventions on quality of life in epilepsy: a randomized controlled trial. Epilepsy Res. 2021, 174:106648. 10.1016\/j.eplepsyres.2021.106648","journal-title":"Epilepsy Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174556","article-title":"Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: an exploratory study","volume":"12","author":"De Weerdt E","year":"2017","unstructured":"De Weerdt E, De Rijdt T, Simoens S, Casteels M, Huys I. Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: an exploratory study. PLoS One. 2017, 12:e0174556. 10.1371\/journal.pone.0174556","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2018.09.005","article-title":"Drug shortages may compromise patient safety: results of a survey of the reference pharmacies of the Drug Commission of German Pharmacists","volume":"122","author":"Said A","year":"2018","unstructured":"Said A, Goebel R, Ganso M, Zagermann-Muncke P, Schulz M. Drug shortages may compromise patient safety: results of a survey of the reference pharmacies of the Drug Commission of German Pharmacists. Health Policy. 2018, 122:1302-9. 10.1016\/j.healthpol.2018.09.005","journal-title":"Health Policy"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2023.01.021","article-title":"Impact of the cefazolin shortage on the selection and cost of parenteral antibiotics during the supply disruption period in Japan: a controlled interrupted time series analysis","volume":"16","author":"Nagano H","year":"2023","unstructured":"Nagano H, Shin JH, Kunisawa S, Fushimi K, Nagao M, Imanaka Y. Impact of the cefazolin shortage on the selection and cost of parenteral antibiotics during the supply disruption period in Japan: a controlled interrupted time series analysis. J Infect Public Health. 2023, 16:467-73. 10.1016\/j.jiph.2023.01.021","journal-title":"J Infect Public Health"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jos.2022.08.004","article-title":"Comparison of ceftriaxone and cefazolin as prophylactic antibiotics for surgical site infection in orthopedic upper extremity surgery: the nationwide shortage of cefazolin in March 2019","volume":"28","author":"Sugiura S","year":"2023","unstructured":"Sugiura S, Shimura H, Fujita K, Ogawa T, Nimura A. Comparison of ceftriaxone and cefazolin as prophylactic antibiotics for surgical site infection in orthopedic upper extremity surgery: the nationwide shortage of cefazolin in March 2019. J Orthop Sci. 2023, 28:1018-22. 10.1016\/j.jos.2022.08.004","journal-title":"J Orthop Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp180441","article-title":"ASHP guidelines on managing drug product shortages","volume":"75","author":"Fox ER","year":"2018","unstructured":"Fox ER, McLaughlin MM. ASHP guidelines on managing drug product shortages. Am J Health Syst Pharm. 2018, 75:1742-50. 10.2146\/ajhp180441","journal-title":"Am J Health Syst Pharm"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2016.08.010","article-title":"Drug shortages: patients and health care providers are all drawing the short straw","volume":"33","author":"Rinaldi F","year":"2017","unstructured":"Rinaldi F, de Denus S, Nguyen A, Nattel S, Bussi\u00e8res JF. Drug shortages: patients and health care providers are all drawing the short straw. Can J Cardiol. 2017, 33:283-6. 10.1016\/j.cjca.2016.08.010","journal-title":"Can J Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181df091b","article-title":"Generic antiepileptic drugs and associated medical resource utilization in the United States","volume":"74","author":"Labiner DM","year":"2010","unstructured":"Labiner DM, Paradis PE, Manjunath R, et al.. Generic antiepileptic drugs and associated medical resource utilization in the United States. Neurology. 2010, 74:1566-74. 10.1212\/WNL.0b013e3181df091b","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25353","article-title":"Switching the manufacturer of antiepileptic drugs is associated with higher risk of seizures: a nationwide study of prescription data in Germany","volume":"84","author":"Lang JD","year":"2018","unstructured":"Lang JD, Kostev K, Onugoren MD, et al.. Switching the manufacturer of antiepileptic drugs is associated with higher risk of seizures: a nationwide study of prescription data in Germany. Ann Neurol. 2018, 84:918-25. 10.1002\/ana.25353","journal-title":"Ann Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1535-7511.2008.00261.x","article-title":"Generic antiepileptic drugs: current controversies and future directions","volume":"8","author":"Privitera MD","year":"2008","unstructured":"Privitera MD. Generic antiepileptic drugs: current controversies and future directions. Epilepsy Curr. 2008, 8:113-7. 10.1111\/j.1535-7511.2008.00261.x","journal-title":"Epilepsy Curr"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12962-023-00441-z","article-title":"Generic drug crisis in Japan and changes leading to the collapse of universal health insurance established in 1961: the case of Kobayashi Kako Co. Ltd","volume":"21","author":"Kosaka M","year":"2023","unstructured":"Kosaka M, Ozaki A, Kaneda Y, et al.. Generic drug crisis in Japan and changes leading to the collapse of universal health insurance established in 1961: the case of Kobayashi Kako Co. Ltd. Cost Eff Resour Alloc. 2023, 21:35. 10.1186\/s12962-023-00441-z","journal-title":"Cost Eff Resour Alloc"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2023.109145","article-title":"Shortages of antiseizure medications in Australia and the association with patient switching, and adherence in a community setting","volume":"141","author":"Welton J","year":"2023","unstructured":"Welton J, Stratton G, Schoeninger B, Low MH, Moody A, D'Souza W. Shortages of antiseizure medications in Australia and the association with patient switching, and adherence in a community setting. Epilepsy Behav. 2023, 141:109145. 10.1016\/j.yebeh.2023.109145","journal-title":"Epilepsy Behav"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2004.06.001","article-title":"Estimating the economic burden of status epilepticus to the health care system","volume":"14","author":"Penberthy LT","year":"2005","unstructured":"Penberthy LT, Towne A, Garnett LK, Perlin JB, DeLorenzo RJ. Estimating the economic burden of status epilepticus to the health care system. Seizure. 2005, 14:46-51. 10.1016\/j.seizure.2004.06.001","journal-title":"Seizure"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2013.08.003","article-title":"Inpatient treatment costs of status epilepticus in adults in Germany","volume":"22","author":"Strzelczyk A","year":"2013","unstructured":"Strzelczyk A, Knake S, Oertel WH, Rosenow F, Hamer HM. Inpatient treatment costs of status epilepticus in adults in Germany. Seizure. 2013, 22:882-5. 10.1016\/j.seizure.2013.08.003","journal-title":"Seizure"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2020.08.029","article-title":"Managing medication supply chains: lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the future","volume":"61","author":"Kuo S","year":"2021","unstructured":"Kuo S, Ou HT, Wang CJ. Managing medication supply chains: lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the future. J Am Pharm Assoc (2003). 2021, 61:e12-5. 10.1016\/j.japh.2020.08.029","journal-title":"J Am Pharm Assoc (2003)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/274379-effects-of-valproic-acid-supply-shortage-on-pharmacy-operations-in-a-region-of-japan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T08:31:32Z","timestamp":1721896292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/274379-effects-of-valproic-acid-supply-shortage-on-pharmacy-operations-in-a-region-of-japan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.65324","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,25]]}}}